tirzepatide sigma GLP-2 (T) Compounded GLP-1/GIP (Tirzepatide) - bmiMD

Certain medications may reduce milk supply, affect the baby or require temporary interruption of nursing Cold medicines, allergy medicines, antibiotics, and antidepressants are common breastfeeding concerns

Manufacturer: Eli Lilly and Company Limited Active Substance(s): TIRZEPATIDE Strength: 12.5mg/per 0.6 ml injection Pack Size: 1 box with 4 pre-filled KwikPens MOUNJARO 12.5mg KwikPen is a once-weekly tirzepatide injection in a pre-filled pen delivering four 12.5mg/0.6ml doses for adults with type 2 diabetes and, in some regions, chronic weight management

Use within 30 days of first injection

As noted above, this is expected and aligns with the protocols design

Most providers want to see proof that you've tried other methods first